Tehran (IP) – The 'Razi COV-Pars' vaccine with an inhaled dose is unique in the world, Razi Vaccine and Serum Research Institute says.

Iran PressIran News: The Head of the Razi Vaccine and Serum Research Institute, Ali Es'haqi announced the progress in the human trials phase of the Iranian vaccine 'Razi COV-Pars.'

The head of the Institute stated that the vaccine was the only one in the world that has an inhaled dose.

He noted that the vaccine's human trial started on February 28, 2021, after going through various preclinical phases.

According to Es'haqi, 13 volunteers who received the vaccine were tested positive for immunogenicity to COVID-19.

According to him, the vaccine was the only one that is used in three doses, of which 2 are injectable doses and one is an inhaled dose.

Es'haghi also announced that the second human testing phase would begin in two or three weeks and 500 volunteers would get the shot.


Read More:

Razi Vaccine Head: 'Cov Pars', an excellent option for corona vaccination

Razi Institute to start Iranian corona vaccine clinical trials soon